PLRX
Closed
Pliant Therapeutics inc
1.17
+0.01 (+0.86%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 1.16
Day's Range: 1.13 - 1.255
Send
sign up or login to leave a comment!
When Written:
25.86
Pliant Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on discovering and developing novel therapies for fibrotic diseases. The company's lead product candidate, PLN-74809, is a small molecule inhibitor of integrin αvβ1 that is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). Pliant Therapeutics also has a pipeline of other product candidates targeting various fibrotic diseases, including liver fibrosis, kidney fibrosis, and skin fibrosis. The company was founded in 2016 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








